SCHEMBL2942216

SCHEMBL2942216

CCN1CCC1C=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9660551 0.86
SCHEMBL1116394 0.86
SCHEMBL2617060 0.86
SCHEMBL15383931 0.84 ALDH1A1 (0.34)
SCHEMBL27541668 0.84 ALDH1A1 (0.34)
Hydrochloric Acid SCHEMBL27491495 0.82 CXCR4 (0.34)
SCHEMBL27516117 0.81 NCF1 (0.30)
SCHEMBL27500012 0.81 SMN1; SMN2 (0.37)
SCHEMBL25619769 0.73 SIGMAR1 (0.33)
SCHEMBL27492396 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4508413-B2 2010-07-21 JP claimed
US-20060270606-A1 Dolastatin 15 derivatives ABBOTT GMBH & CO., KG (DE) 2006-11-30 US claimed
EP-0991658-B1 DOLASTATIN 15 DERIVATIVES ABBOTT GMBH & CO KG (DE) 2005-12-28 EP claimed
US-20030153505-A1 Dolastatin 15 derivatives BASF AKTIENGESELLSCHAFT (DE) 2003-08-14 US claimed
US-6143721-A FOR TREATING CANCER IN MAMMALS BASF AKTIENGESELLSCHAFT (DE) 2000-11-07 US claimed
EP-0991658-A1 DOLASTATIN 15 DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-04-12 EP claimed
WO-1999003879-A1 DOLASTATIN 15 DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 1999-01-28 WO claimed
CN-101665509-A 4 pos-1H-1,2,3-triazole-beta-lactam derivative and preparation method thereof UNIV ZHEJIANG 2010-03-10 CN disclosed
CN-101665508-A Preparation method of 4-1H-1,2,3-triazole-beta-lactam derivative UNIV ZHEJIANG 2010-03-10 CN disclosed